An open study to assess the safety and efficacy of Aesculus hippocastanum tablets (Aesculaforce® 50mg) in the treatment of chronic venous insufficiency

Journal of Herbal Pharmacotherapy

Volumn 4, Issue 2, 2004, Pages 19-32

  Dickson, Sylvia ^a   Gallagher, Julie ^a   McIntyre, Lorna ^a   Suter, Andy ^b   Tan, Jen ^a  

^a Bioforce (UK) Ltd   (United Kingdom)

^b Bioforce AG   (Switzerland)

Author keywords

Aesculaforce ; Chronic venous insufficiency; Horse chestnut

Indexed keywords

AESCULAFORCE; AESCULUS HIPPOCASTANUM EXTRACT;

ADULT; AESCULUS HIPPOCASTANUM; AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; CHRONIC VEIN INSUFFICIENCY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ENTERIC COATED TABLET; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; OPEN STUDY; PHOTOELECTRIC PLETHYSMOGRAPHY; PLANT SEED; PRIORITY JOURNAL; RATING SCALE; STOMACH PAIN; SYMPTOMATOLOGY; TREATMENT OUTCOME;

AESCULUS; AGED; ANTI-INFLAMMATORY AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; LEG; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PATIENT COMPLIANCE; PHYTOTHERAPY; PLANT EXTRACTS; REGIONAL BLOOD FLOW; TIME FACTORS; TREATMENT OUTCOME; VENOUS INSUFFICIENCY;

EID: 8744283692     PISSN: 15228940     EISSN: None     Source Type: Journal    
DOI: 10.1300/J157v04n02_03     Document Type: Article

References (13)

1. Angle N & Bergan JJ (1997) Chronic venous ulcer. British Medical Journal 314 (1019).
2. Bosanquet N (1992) Costs of venous ulcers: From maintenance therapy to invest ment programmes. Phlebology (1), pp. 44-46.
3. Mills S & Bone K (2000) Principles and Practice of Phytotherapy. Churchill Livingstone.
4. Alexander MF, Fawcett JN & Runciman PJ (1994) Nursing Practice: Hospital and Home. Churchill Livingston.
5. Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JD, Martin JB, Kasper DL, Hauser SL & Longo DL (1998) Harrison's Principles of Internal Medicine. McGraw-Hill 14th Edition, Volume 2.
6. Ernst E (2001) The Desktop Guide To Complementary and Alternative Medicine, an Evidence-Based Approach. Harcourt Publishers Limited.
7. ESCOP (1999) European scientific cooperative of phytotherapy. Monograph on medicinal uses of plant drugs.
8. Schultz-Ehrenburg U & Blazek V (2001) Value of quantitative photoplethysmography for functional vascular diagnostics. Skin Pharmacology and Applied Skin Physiology 14, pp. 316-323.
9. Marston WA (2002) PPG, APG, Duplex: Which non-invasive tests are most appropriate for the management of patients with chronic venous insufficiency? Seminars in Vascular Surgery 15 (1), pp. 13-20.
10. Shah D, Bommer S & Degenring FH (1997) Aesculaforce® in chronic venous insufficiency. Schweiz. Zschr. GanzheitsMedizin.
11. Geissbuehler S & Degenring FH (1999) Treatment of chronic venous insufficiency with Aesculaforce® Vein Gel. Schweiz. Zschr. GanzheitsMedizin 11, pp. 82-87.
12. Siebert U, Brach M, Srocyzynski G & Uberla K (2002) Efficacy, routine effectiveness and safety of horsechestnut seed extract in the treatment of chronic venous insufficiency, International Angiology 21 (4), pp. 305-315.
13. Pittler MH & Ernst E (2003) Horse chestnut seed extract for chronic venous insufficiency (Cochrane Review) in: The Cochrane Library (1), Oxford: Update Software. pp. 1-18.